SBL
RMD icon

Sargent Bickham Lagudis’s ResMed RMD Stock Holding History

Sargent Bickham Lagudis’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$52K Hold
250
– – ﹤0.01% 431
2022
Q3 		$55K Hold
250
– – ﹤0.01% 394
2022
Q2 		$52K Hold
250
– – ﹤0.01% 414
2022
Q1 		$61K Sell
250
-7
-3% -$1.69K ﹤0.01% 415
2021
Q4 		$67K Sell
257
-43
-14% -$11.2K 0.01% 404
2021
Q3 		$79K Hold
300
– – 0.01% 365
2021
Q2 		$74K Hold
300
– – 0.01% 384
2021
Q1 		$58K Buy
+300
New +$60.2K 0.01% 415

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

Sargent Bickham Lagudis's RMD Position: Q4 2022 in Review

Sargent Bickham Lagudis held its ResMed (RMD) position steady in Q4 2022 at 250 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #431.

Sargent Bickham Lagudis first reported a position in RMD in Q1 2021 and has held it in 8 quarters since. The position peaked at $79K in Q3 2021. 731 funds tracked by Wall St. Rank hold RMD as of Q4 2022.

  • Sargent Bickham Lagudis held 250 shares of ResMed worth $52K as of Q4 2022.
  • Sargent Bickham Lagudis left its ResMed share count unchanged in Q4 2022.
  • ResMed made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #431 holding.
  • Sargent Bickham Lagudis first reported a position in ResMed in Q1 2021 and has held it in 8 quarters since.
  • Sargent Bickham Lagudis's ResMed position peaked at $79K in Q3 2021.
  • 731 funds tracked by Wall St. Rank held ResMed as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.